Related Experiment Videos
Complex chimeras to map ligand binding sites of GPCRs
K L Gearing1, A Barnes, J Barnett
1Department of Gene Expression and Protein Biochemistry, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK. katy.l.gearing@gsk.com
Protein Engineering
|June 27, 2003
Summary
Researchers engineered G-protein coupled receptors (GPCRs) to identify ligand binding sites. This study successfully transposed the binding determinants of one receptor onto another, confirming their location and function.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Family 1a G-protein coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- These receptors are known to bind small molecule ligands within a complex pocket formed by non-contiguous transmembrane helices.
- Understanding the precise determinants of ligand binding is essential for drug discovery and therapeutic development.
Purpose of the Study:
- To define the specific receptor-ligand binding determinants within Family 1a GPCRs.
- To engineer chimeric receptors to transpose ligand binding sites between related GPCRs.
- To validate the location and functional transferability of these binding determinants.
Main Methods:
- Construction of complex chimeric receptors by exchanging sequences between related GPCRs (P2Y1, P2Y2, and BLT1).
- Engineering of transmembrane helices to transpose specific ligand binding sites.
- Assessment of ligand-induced receptor activation using a yeast reporter gene assay.
- Comparison of chimera activation with wild-type receptor activity.
Main Results:
- Identification of specific regions within P2Y1, P2Y2, and BLT1 receptors responsible for nucleotide and leukotriene ligand interactions.
- Successful transposition of the BLT1 receptor's ligand binding site onto a different receptor scaffold.
- Confirmation that BLT1 binding determinants reside in the upper transmembrane helices and extracellular loops.
- Demonstration that these determinants can confer binding to a receptor that normally interacts with unrelated ligands.
Conclusions:
- The ligand binding determinants for Family 1a GPCRs are localized to specific regions within the transmembrane helices and extracellular loops.
- Receptor engineering strategies can successfully transpose ligand binding specificity between GPCRs.
- This research provides a foundation for designing novel GPCR-targeting therapeutics by understanding and manipulating ligand-receptor interactions.